Insmed Inc [NASDAQ: INSM] traded at a high on 2025-10-30, posting a 16.33 gain after which it closed the day’ session at $194.22.
The results of the trading session contributed to over 6733226 shares changing hands. Over the past one week, the price volatility of Insmed Inc stands at 5.17% while the volatility over the past one month is 3.53%.
The market cap for INSM stock reached $41.05 billion, with 211.11 million shares outstanding and 207.26 million shares in the current float. Compared to the average trading volume of 2.42M shares, INSM reached a trading volume of 6733226 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Insmed Inc [INSM]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for INSM shares is $196.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on INSM stock is a recommendation set at 1.15. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cantor Fitzgerald have made an estimate for Insmed Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on October 28, 2025. While these analysts kept the previous recommendation, Wells Fargo raised their target price to Overweight. The new note on the price target was released on October 20, 2025, representing the official price target for Insmed Inc stock.
The Price to Book ratio for the last quarter was 32.81, with the Price to Cash per share for the same quarter was set at 8.78.
How has INSM stock performed recently?
Insmed Inc [INSM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 21.30. With this latest performance, INSM shares gained by 31.87% in over the last four-week period, additionally plugging by 167.37% over the last 6 months – not to mention a rise of 181.32% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for INSM stock in for the last two-week period is set at 82.73, with the RSI for the last a single of trading hit 7.08, and the three-weeks RSI is set at 5.52 for Insmed Inc [INSM]. The present Moving Average for the last 50 days of trading for this stock 150.79, while it was recorded at 170.03 for the last single week of trading, and 101.09 for the last 200 days.
Insmed Inc [INSM]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Insmed Inc [INSM] shares currently have an operating margin of -233.02% and a Gross Margin at 74.45%. Insmed Inc’s Net Margin is presently recorded at -259.82%.
Insmed Inc (INSM) Capital Structure & Debt Analysis
According to recent financial data for Insmed Inc. ( INSM), the Return on Equity (ROE) stands at -160.54%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -48.22%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Insmed Inc’s Return on Invested Capital (ROIC) is -52.18%, showcasing its effectiveness in deploying capital for earnings.
Insmed Inc (INSM) Efficiency & Liquidity Metrics
Based on Insmed Inc’s (INSM) latest financial statements, the Debt-to-Equity Ratio is 0.59%, indicating its reliance on debt financing relative to shareholder equity.
Insmed Inc (INSM) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Insmed Inc. (INSM) effectively leverages its workforce, generating an average of -$810385.52 per employee. The company’s liquidity position is robust, with a Current Ratio of 6.68% and a Quick Ratio of 6.33%, indicating strong ability to cover short-term liabilities.
Earnings analysis for Insmed Inc [INSM]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for INSM. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Insmed Inc go to 61.09%.
Insider trade positions for Insmed Inc [INSM]
There are presently around $103.98%, or 104.66%% of INSM stock, in the hands of institutional investors. The top three institutional holders of INSM stocks are: VANGUARD GROUP INC with ownership of 16.01 million shares, which is approximately 10.3509%. BLACKROCK INC., holding 14.26 million shares of the stock with an approximate value of $$955.72 million in INSM stocks shares; and BLACKROCK INC., currently with $$814.95 million in INSM stock with ownership which is approximately 7.8625%.
